On the Matter of Regulating CBD
Today, James Zuko, an observer of the regulatory process in Washington DC with particular experience in drug development and FDA compliance, comments on the growing rumor that the FDA will soon issue a guidance that treats CBD as a drug, not as a food supplement. I am biased. I am talking about the federal powers, …